BioSpace News Archive

FDA approved BRAFTOVI™ (encorafenib) in combination with MEKTOVI® (binimetinib) for advanced BRAF-mutant melanoma

MedAfford Global Inc. (MGI), an international discount brand-name medication facilitator announces a partnership with an international Pharmacy Benefit Manager (PBM).

HH&Y Will Begin Leveraging InTouchMD’s Suite of Technology Products Next Month

Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors

The program offers free online courses for physical therapists, personal trainers and group fitness professionals to create safe and effective exercise classes for people living with Parkinson’s

ETX2514SUL was generally well tolerated

inVibe Labs has just expanded its Philadelphia-based team with the hiring of two healthcare industry veterans, Beth Baldys and Donna Wray.

Onspira Therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational product, OSP-101

CANbridge Life Sciences, a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that the China National Drug Administration (CNDA) has approved the Investigational New Drug (IND) application for a Phase Ib/III clinical study of CAN017 in esophageal squamous cell cancer (ESCC).

Pure Applied Sciences, a wholly own subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), begins production of Halo Filters. Halo Filters is the company’s patent pending, cannabis smoke filtration pre-roll cone. I